Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study

Yue-Yang Zhang,Bing-Xue Chen,Qin Wan
DOI: https://doi.org/10.1186/s13098-024-01477-8
2024-10-06
Diabetology & Metabolic Syndrome
Abstract:The pathogenesis of type 2 diabetes mellitus is somewhat associated with lipid metabolism. We aim to assess the impact of lipid-lowering drugs ( HMGCR inhibitors, PCSK9 inhibitors, and NPC1L1 inhibitors) on type 2 diabetes mellitus and its complications through a two-sample Mendelian randomization (MR) study.
endocrinology & metabolism
What problem does this paper attempt to address?